2025
Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults
Du Z, Pandey A, Moghadas S, Bai Y, Wang L, Matrajt L, Singer B, Galvani A. Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults. Nature Medicine 2025, 31: 647-652. PMID: 39789324, PMCID: PMC11835734, DOI: 10.1038/s41591-024-03431-7.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusSyncytial virusRSV diseaseImpact of vaccinationBurden of respiratory syncytial virusVaccination of pregnant womenRSV-related mortalityProtein-based vaccinesVaccination of older adultsRSV vaccinePregnant womenSeasonal influenzaVaccine uptake ratesInfant hospitalizationClinical trialsPrefusion FHospital costsInfantsHealth burdenAdult immunizationVaccineOlder adultsHospitalEnhanced uptakeHigh-income countries
2024
Parent Perspectives on Nirsevimab for Their Newborn.
Hinderstein S, Aragona E, Loyal J. Parent Perspectives on Nirsevimab for Their Newborn. 2024, 154 PMID: 39587878, DOI: 10.1542/peds.2024-067532.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusRespiratory syncytial virus prophylaxisRSV disease severityMaternal RSV vaccineHealth Belief ModelHealthy newbornsRSV vaccineRSV infectionParents of newbornsNewborn unitSyncytial virusNirsevimabSide effectsNewbornsBelief ModelPediatric hospitalMonoclonal antibodiesDisease severityCOVID-19 vaccineProphylaxisVaccineIncreasing overall awarenessInfantsPediatrician's recommendationPositively influence decisionEnhanced placental antibody transfer efficiency with longer interval between maternal respiratory syncytial virus vaccination and birth
Jasset O, Lopez Zapana P, Bahadir Z, Shook L, Dennis M, Gilbert E, Liu Z, Yinger R, Bald C, Bradford C, Silfen A, Klein S, Pekosz A, Permar S, Konnikova L, Yonker L, Lauffenburger D, Nelson A, Elovitz M, Edlow A. Enhanced placental antibody transfer efficiency with longer interval between maternal respiratory syncytial virus vaccination and birth. American Journal Of Obstetrics And Gynecology 2024, 232: 554.e1-554.e15. PMID: 39515450, PMCID: PMC12056162, DOI: 10.1016/j.ajog.2024.10.053.Peer-Reviewed Original ResearchMaternal RSV vaccineRespiratory syncytial virusRespiratory syncytial virus vaccineNatural RSV infectionRSV vaccineRSV infectionBinding antibody multiplex assayTiming of maternal vaccinationTransplacental transfer of maternal antibodiesAntibody levelsRespiratory syncytial virus strains A2Vaccine administrationInfant antibody levelsMaternal antibodiesMother to fetusProspective cohort studyTransfer of maternal antibodiesWilcoxon rank sum testWeek windowVaccination timingLevels of IgGRank sum testTransfer of antibodiesMonths of ageGestational age
2023
Coverage with Influenza, Respiratory Syncytial Virus, and Updated COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, December 2023
Reses H, Dubendris H, Haas L, Barbre K, Ananth S, Rowe T, Mothershed E, Hall E, Wiegand R, Lindley M, Meyer S, Patel S, Benin A, Kroop S, Srinivasan A, Bell J. Coverage with Influenza, Respiratory Syncytial Virus, and Updated COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, December 2023. MMWR Morbidity And Mortality Weekly Report 2023, 72: 1371-1376. PMID: 38127673, PMCID: PMC10754267, DOI: 10.15585/mmwr.mm7251a3.Peer-Reviewed Original ResearchConceptsRespiratory syncytial virusNursing home residentsNational Healthcare Safety NetworkRespiratory virus seasonHome residentsVaccination coverageRespiratory virusesSyncytial virusCDC's National Healthcare Safety NetworkCOVID-19COVID-19 vaccination coverageHuman Services (HHS) regionsCOVID-19 vaccineSARS-CoV-2RSV vaccineSevere complicationsRespiratory illnessSevere outcomesNursing homesEligible residentsVaccinationInfluenzaSafety NetworkOlder adultsVaccine
2015
Natural history and epidemiology of respiratory syncytial virus infection in the Middle East: Hospital surveillance for children under age two in Jordan
Halasa N, Williams J, Faouri S, Shehabi A, Vermund SH, Wang L, Fonnesbeck C, Khuri-Bulos N. Natural history and epidemiology of respiratory syncytial virus infection in the Middle East: Hospital surveillance for children under age two in Jordan. Vaccine 2015, 33: 6479-6487. PMID: 26314623, PMCID: PMC7115487, DOI: 10.1016/j.vaccine.2015.08.048.Peer-Reviewed Original ResearchMeSH KeywordsEpidemiological MonitoringFemaleHospitalsHumansInfantInfant, NewbornJordanMaleMass SpectrometryNasal MucosaPharynxPrevalenceProspective StudiesReal-Time Polymerase Chain ReactionRespiratory Syncytial Virus InfectionsRespiratory Tract InfectionsReverse Transcriptase Polymerase Chain ReactionRisk FactorsVitamin DConceptsRespiratory syncytial virusRSV-positive childrenVitamin D levelsD levelsRespiratory virusesRisk factorsMedical conditionsBurden of RSVOxygen useMedian vitamin D levelNasal/throat swabsRespiratory syncytial virus infectionCause of bronchiolitisHeel stick bloodSyncytial virus infectionLack of breastfeedingSupplemental oxygen useHigh viral loadFuture RSV vaccinesYoung childrenReal-time RT-PCRRSV hospitalizationRespiratory symptomsRSV vaccineAntiviral therapy
2010
Burden of respiratory syncytial virus in hospitalized infants and young children in Amman, Jordan
Khuri-Bulos N, Williams JV, Shehabi AA, Faouri S, Al Jundi E, Abushariah O, Chen Q, Ali SA, Vermund S, Halasa NB. Burden of respiratory syncytial virus in hospitalized infants and young children in Amman, Jordan. Infectious Diseases 2010, 42: 368-374. PMID: 20100116, PMCID: PMC2854220, DOI: 10.3109/00365540903496544.Peer-Reviewed Original ResearchMeSH KeywordsAge FactorsCost of IllnessFemaleHospitalizationHumansInfantJordanLength of StayMaleMiddle EastNosePharynxPrevalenceProspective StudiesRespiratory Syncytial Virus InfectionsRespiratory Syncytial Virus, HumanReverse Transcriptase Polymerase Chain ReactionRNA, ViralSex FactorsUnited StatesConceptsAcute respiratory infectionsMedian ageNose/throat swabsRespiratory syncytial virus seasonChildren's median ageRSV-negative childrenRSV-positive childrenSpecific viral causeLonger hospital stayHigher hospital chargesIntensive care unitRespiratory syncytial virusReal-time polymerase chain reactionLower median ageEffective preventive measuresJordanian infantsHospital stayHospitalized infantsRSV vaccineRespiratory infectionsCare unitHospital chargesSyncytial virusThroat swabsViral cause
2001
Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV Challenge
Kahn J, Roberts A, Weibel C, Buonocore L, Rose J. Replication-Competent or Attenuated, Nonpropagating Vesicular Stomatitis Viruses Expressing Respiratory Syncytial Virus (RSV) Antigens Protect Mice against RSV Challenge. Journal Of Virology 2001, 75: 11079-11087. PMID: 11602747, PMCID: PMC114687, DOI: 10.1128/jvi.75.22.11079-11087.2001.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, IntranasalAnimalsAntigens, ViralBase SequenceCell LineCricetinaeFemaleMiceMice, Inbred BALB CMolecular Sequence DataRespiratory Syncytial Virus InfectionsVaccines, AttenuatedVaccines, SyntheticVesicular stomatitis Indiana virusViral ProteinsViral VaccinesVirus ReplicationConceptsRespiratory syncytial virusRSV challengeRecombinant vesicular stomatitis virusVesicular stomatitis virusRSV FRespiratory syncytial virus GRSV-specific antibodiesDetectable neutralizing antibodiesDetectable serum antibodiesStomatitis virusIntranasal vaccinationRSV vaccineRSV GProtective immunitySyncytial virusDetectable serumNeutralizing antibodiesSerum antibodiesMouse modelRSV proteinsComplete protectionReplication competentAntibodiesG glycoproteinVirus
1999
Recombinant Vesicular Stomatitis Virus Expressing Respiratory Syncytial Virus (RSV) Glycoproteins: RSV Fusion Protein Can Mediate Infection and Cell Fusion
Kahn J, Schnell M, Buonocore L, Rose J. Recombinant Vesicular Stomatitis Virus Expressing Respiratory Syncytial Virus (RSV) Glycoproteins: RSV Fusion Protein Can Mediate Infection and Cell Fusion. Virology 1999, 254: 81-91. PMID: 9927576, DOI: 10.1006/viro.1998.9535.Peer-Reviewed Original ResearchMeSH KeywordsAmino Acid SequenceAnimalsBinding SitesCell LineCricetinaeCytoplasmGene ExpressionGenetic VectorsGlycoproteinsHN ProteinHumansMembrane FusionMolecular Sequence DataRecombinant Fusion ProteinsRespiratory Syncytial Virus, HumanTumor Cells, CulturedVesicular stomatitis Indiana virusViral Envelope ProteinsViral Fusion ProteinsViral ProteinsVirionConceptsRecombinant vesicular stomatitis virusVesicular stomatitis virusRSV fusion proteinRSV F glycoproteinRSV vaccineF recombinantsRSV glycoproteinsRSV proteinsEnvelope glycoproteinVirus attachmentFusion (F) envelope glycoproteinsF glycoproteinG glycoproteinStomatitis virusLarge syncytiaGlycoproteinPH-independent pathwayCell surfaceCell fusionCytoplasmic tail sequencesVSV G.Endosomal pHFusion activityVaccineFusion protein
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply